Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Neostigmine Methylsulfate Injection

Approval Number

国药准字H20233878

Company成都苑东生物制药股份有限公司

Registration Date

June 30, 2023

Drug Information

Generic Name

甲硫酸新斯的明注射液

Dosage Form

注射剂

Strength

4ml:2mg

Drug Type

化学药品

Registration Date

June 30, 2023

Company Information

Applicant Company

Company Name成都苑东生物制药股份有限公司

Company Address

成都高新区西源大道8号

Manufacturing Company

Company Name成都苑东生物制药股份有限公司

Company Address

成都高新区西源大道8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

甲硫酸新斯的明注射液 - NMPA 批准文号 | MedPath